RxDoctor Payments DataLook up a doctor →

Amitabh Gulati, MD

Pain Medicine · New York, NYNPI 1285855486

Payments from drug & device makers

$627,006in general payments, 2019–2025

Across 695 payments — averaging $902.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$335K
  • Medtronic$169K
  • Nalu Medical, Inc.$38K
  • Hinge Health, Inc.$34K
  • Rivanna Medical, Inc$23K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$8K
  • plus $20K from 26 others

What the payments were for

  • Consulting fees$383,14162%
  • Speaking & faculty fees$120,38820%
  • Grants$3,9471%
  • Travel & lodging$57,7899%
  • Food & beverage$47,6688%
  • Gifts$3920%
  • Entertainment$1,0830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$627,006 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$91,170
Medicare patients
281
Services billed
1,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucyntaTapentadol Hcl35$53,235
OxycontinOxycodone Hcl45$39,627
Xtampza ErOxycodone Myristate21$29,739
Fentanyl80$13,337
LyricaPregabalin12$10,319
Hydromorphone ErHydromorphone Hcl35$9,630
Oxycodone Hcl300$8,275
Lidocaine69$6,690
Oxymorphone Hcl ErOxymorphone Hcl11$6,319
Buprenorphine12$4,275
Gabapentin224$3,579
Pregabalin161$3,533
Hydromorphone Hcl114$2,508
Naloxone Hcl30$1,852
Morphine Sulfate58$1,778

Paid to pharmacies, not to this prescriber.

Other pain medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →